Cerebrovascular reactivity and cerebral perfusion of rats with acute liver failure: role of L‐glutamine and asymmetric dimethylarginine in L‐arginine‐induced response

Cerebral blood flow (CBF) is impaired in acute liver failure (ALF), however, the complexity of the underlying mechanisms has often led to inconclusive interpretations. Regulation of CBF depends at least partially on variations in the local brain L‐arginine concentration and/or its metabolic rate. In ALF, other factors, like an increased concentration of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor and elevated level of L‐glutamine, may contribute to CBF alteration. This study demonstrated strong differences in the reactivity of the middle cerebral arteries and their response to extravascular L‐arginine application between vessels isolated from rats with thioacetamide (TAA)‐induced ALF and control animals. Our results also showed the decrease in the cerebral perfusion in TAA rats measured by arterial spin labeling perfusion magnetic resonance. Subsequently, we aimed to investigate the importance of balance between the concentration of ADMA and L‐arginine in the CBF regulation. In vivo, intraperitoneal L‐arginine administration in TAA rats corrected: (i) decrease in cerebral perfusion, (ii) decrease in brain extracellular L‐arginine/ADMA ratio and (iii) increase in brain L‐glutamine concentration. Our study implicates that impaired vascular tone of cerebral arteries is most likely associated with exposure to high ADMA and L‐glutamine levels resulting in limited availability of L‐arginine and might be responsible for reduced cerebral perfusion observed in ALF.

[1]  S. DeMorrow,et al.  Recent advances in hepatic encephalopathy , 2017, F1000Research.

[2]  R. Butterworth,et al.  Brain Glutamine Accumulation in Liver Failure , 2017 .

[3]  B. Dworakowska,et al.  Restoration of the response of the middle cerebral artery of the rat to acidosis in hyposmotic hyponatremia by the opener of large-conductance calcium sensitive potassium channels (BKCa) , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  M. Zielińska,et al.  Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association? , 2016, Neurochemical Research.

[5]  M. Zielińska,et al.  Intracerebral Administration of S-Adenosylhomocysteine or S-Adenosylmethionine Attenuates the Increases in the Cortical Extracellular Levels of Dimethylarginines Without Affecting cGMP Level in Rats with Acute Liver Failure , 2016, Neurotoxicity Research.

[6]  J. Córdoba,et al.  Gene expression profiling of brain cortex microvessels may support brain vasodilation in acute liver failure rat models , 2016, Metabolic Brain Disease.

[7]  J. Filosa,et al.  Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone , 2016, Neuroscience.

[8]  M. Skowrońska,et al.  Induction of inducible nitric oxide synthase expression in ammonia‐exposed cultured astrocytes is coupled to increased arginine transport by upregulated y+LAT2 transporter , 2015, Journal of neurochemistry.

[9]  M. Zielińska,et al.  The dimethylarginine (ADMA)/nitric oxide pathway in the brain and periphery of rats with thioacetamide-induced acute liver failure: Modulation by histidine , 2015, Neurochemistry International.

[10]  K. Mouridsen,et al.  Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [11C]acetate in humans , 2014, Front. Neurosci..

[11]  M. Zielińska,et al.  Citrulline uptake in rat cerebral cortex slices: Modulation by Thioacetamide -Induced hepatic failure , 2014, Metabolic Brain Disease.

[12]  Vicente Felipo,et al.  Hepatic encephalopathy: effects of liver failure on brain function , 2013, Nature Reviews Neuroscience.

[13]  R. Butterworth The liver–brain axis in liver failure: neuroinflammation and encephalopathy , 2013, Nature Reviews Gastroenterology &Hepatology.

[14]  Ze Wang,et al.  Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: an arterial spin labeling MR study. , 2012, European journal of radiology.

[15]  Q. Dong,et al.  Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke , 2012, International journal of molecular sciences.

[16]  S. Bode-Böger,et al.  Quantification of L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma: a step improvement in precision by stable isotope dilution mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  M. Skowrońska,et al.  Upregulation of the heteromeric y+LAT2 transporter contributes to ammonia-induced increase of arginine uptake in rat cerebral cortical astrocytes , 2012, Neurochemistry International.

[18]  M. Zielińska,et al.  Hyperammonemia increases the expression and activity of the glutamine/arginine transporter y+LAT2 in rat cerebral cortex: Implications for the nitric oxide/cGMP pathway , 2011, Neurochemistry International.

[19]  D. Attwell,et al.  Glial and neuronal control of brain blood flow , 2010, Nature.

[20]  F. Palm,et al.  Cellular ADMA: regulation and action. , 2009, Pharmacological research.

[21]  M. Zielińska,et al.  Glutamine inhibits ammonia-induced accumulation of cGMP in rat striatum limiting arginine supply for NO synthesis , 2009, Neurobiology of Disease.

[22]  Peter Ott,et al.  Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. , 2009, Gastroenterology.

[23]  G. Alexander,et al.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection , 2008, The Journal of experimental medicine.

[24]  G. Corso,et al.  Determination of dimethylarginine levels in rats using HILIC-MS/MS: an in vivo microdialysis study. , 2008, Journal of separation science.

[25]  G. Knudsen,et al.  Cerebral Blood Flow Autoregulation in Experimental Liver Failure , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  B. MacVicar,et al.  Astrocyte control of the cerebrovasculature , 2007, Glia.

[27]  P. Bentzer,et al.  Effects of L-arginine on cerebral blood flow, microvascular permeability, number of perfused capillaries, and brain water content in the traumatized mouse brain. , 2007, Microvascular research.

[28]  L. Ignarro,et al.  The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. , 2007, Pharmacology & therapeutics.

[29]  G. Strauss The effect of hyperventilation upon cerebral blood flow and metabolism in patients with fulminant hepatic failure. , 2007, Danish medical bulletin.

[30]  J. Zweier,et al.  Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function* , 2007, Journal of Biological Chemistry.

[31]  T. Bacchella,et al.  Hypertonic saline solution increases cerebral perfusion pressure during clinical orthotopic liver transplantation for fulminant hepatic failure: preliminary results. , 2006, Clinics.

[32]  Eric A Newman,et al.  Glial Cells Dilate and Constrict Blood Vessels: A Mechanism of Neurovascular Coupling , 2006, The Journal of Neuroscience.

[33]  S. Moncada,et al.  The discovery of nitric oxide and its role in vascular biology , 2006, British journal of pharmacology.

[34]  F. Larsen,et al.  Persistent Arterial Hyperammonemia Increases the Concentration of Glutamine and Alanine in the Brain and Correlates with Intracranial Pressure in Patients with Fulminant Hepatic Failure , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  R. Koehler,et al.  Glutamine-dependent inhibition of pial arteriolar dilation to acetylcholine with and without hyperammonemia in the rat. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  P. Bath,et al.  A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. , 2005, Nitric oxide : biology and chemistry.

[37]  R. Böger,et al.  L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[38]  P. Hayes,et al.  Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. , 2004, Journal of hepatology.

[39]  J. Garthwaite,et al.  Nitric oxide and its role in ischaemic brain injury. , 2004, Current molecular medicine.

[40]  R. Butterworth Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[41]  F. Larsen Cerebral Blood Flow in Hyperammonemia: Heterogeneity and Starling Forces in Capillaries , 2002, Metabolic Brain Disease.

[42]  D. Geller,et al.  Blockade of the L‐arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury , 2002, Hepatology.

[43]  M. Manns,et al.  Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones , 2002, Clinical transplantation.

[44]  D. Tsikas,et al.  Endogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox , 2000, FEBS letters.

[45]  R. Koehler,et al.  Interaction of glutamine and arginine on cerebrovascular reactivity to hypercapnia. , 2000, American journal of physiology. Heart and circulatory physiology.

[46]  T. Ebner,et al.  Nitric oxide is the predominant mediator of cerebellar hyperemia during somatosensory activation in rats. , 1999, The American journal of physiology.

[47]  D. Pelligrino,et al.  Effects of some guanidino compounds on human cerebral arteries. , 1999, Stroke.

[48]  Ulrich Dirnagl,et al.  Nitric oxide: a modulator, but not a mediator, of neurovascular coupling in rat somatosensory cortex. , 1999, American journal of physiology. Heart and circulatory physiology.

[49]  R. Koehler,et al.  Preserved hypocapnic pial arteriolar constriction during hyperammonemia by glutamine synthetase inhibition. , 1999, American journal of physiology. Heart and circulatory physiology.

[50]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[51]  A. Haase,et al.  In Vivo quantitative mapping of cardiac perfusion in rats using a noninvasive MR spin‐labeling method , 1998, Journal of magnetic resonance imaging : JMRI.

[52]  D. Harrison,et al.  Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.

[53]  J. Hennig,et al.  Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. , 1997, Gastroenterology.

[54]  R. Butterworth,et al.  Portacaval Shunting and Hyperammonemia Stimulate the Uptake of l‐[3H]Arginine but Not of l‐[3H]Nitroarginine into Rat Brain Synaptosomes , 1997, Journal of neurochemistry.

[55]  J. Albrecht,et al.  Relation of taurine transport and brain edema in rats with simple hyperammonemia or liver failure , 1996, Journal of neuroscience research.

[56]  H. Hansen,et al.  Visually evoked cerebral blood flow velocity changes in different states of brain dysfunction. , 1996, Stroke.

[57]  C. C. Lai,et al.  Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline. , 1996, The Journal of pharmacology and experimental therapeutics.

[58]  K. Sugita,et al.  Regional differences in cerebral vasomotor control by nitric oxide , 1995, Brain Research Bulletin.

[59]  D. Heistad,et al.  Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. , 1995, The American journal of physiology.

[60]  D. Harrison,et al.  Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. , 1995, The Journal of clinical investigation.

[61]  T. J. Lee,et al.  Arginine synthesis from citrulline in perivascular nerves of cerebral artery. , 1995, The Journal of pharmacology and experimental therapeutics.

[62]  H. Yonas,et al.  Regional Cerebral Blood Flow and CO2 Reactivity in Fulminant Hepatic Failure , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[63]  R. Dacey,et al.  Nitric Oxide Regulates Cerebral Arteriolar Tone in Rats , 1994, Stroke.

[64]  J. Olson,et al.  Brain Ion and Amino Acid Contents During Edema Development in Hepatic Encephalopathy , 1994, Journal of neurochemistry.

[65]  C. Iadecola,et al.  Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? , 1993, Trends in Neurosciences.

[66]  M. Moskowitz,et al.  l‐Arginine dilates rat pial arterioles by nitric oxide‐dependent mechanisms and increases blood flow during focal cerebral ischaemia , 1992, British journal of pharmacology.

[67]  S. Ueno,et al.  Distribution of Free Methylarginines in Rat Tissues and in the Bovine Brain , 1992, Journal of neurochemistry.

[68]  R. Koehler,et al.  Restoration of cerebrovascular CO2 responsivity by glutamine synthesis inhibition in hyperammonemic rats. , 1992, Circulation research.

[69]  Z Benyó,et al.  Effects of NG‐nitro‐L‐arginine and L‐arginine on regional cerebral blood flow in the cat. , 1992, The Journal of physiology.

[70]  D. Heistad,et al.  Does basal production of nitric oxide contribute to regulation of brain-fluid balance? , 1992, The American journal of physiology.

[71]  F. Faraci Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. , 1991, The American journal of physiology.

[72]  P. Black,et al.  L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. , 1991, The Journal of clinical investigation.

[73]  J. Vane,et al.  The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. H. Nelson,et al.  Endothelium-dependent L-Arg- and L-NMMA-sensitive mechanisms regulate tone of brain microvessels. , 1990, The American journal of physiology.

[75]  F. Faraci Role of nitric oxide in regulation of basilar artery tone in vivo. , 1990, The American journal of physiology.

[76]  J. Albrecht,et al.  Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide‐induced hepatic encephalopathy: An adaptative response? , 1990, Journal of neuroscience research.

[77]  M. Rizzo,et al.  Blindsight: A case study and implications by L. Weiskrantz, Oxford University Press, 1986. £ 19.50 (viii + 187 pages) ISBN 9 18 852129 4 , 1987, Trends in Neurosciences.

[78]  R. Butterworth,et al.  Amino Acid Changes in Autopsied Brain Tissue from Cirrhotic Patients with Hepatic Encephalopathy , 1987, Journal of neurochemistry.

[79]  F. Plum,et al.  Biochemistry and physiology of brain ammonia. , 1987, Physiological reviews.

[80]  J. Albrecht,et al.  Changes in arterial and cerebral venous blood gases, cerebral blood flow and cerebral oxygen consumption at different stages of thioacetamide-induced hepatogenic encephalopathy in rat. , 1986, Resuscitation.

[81]  M. Norenberg,et al.  Fine structural localization of glutamine synthetase in astrocytes of rat brain , 1979, Brain Research.

[82]  D. Heistad,et al.  Regulation of large cerebral arteries and cerebral microvascular pressure. , 1990, Circulation research.

[83]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .